Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Prostatic Neoplasms"" wg kryterium: Temat


Tytuł :
Comparative Analysis of Genomic Alterations across Castration Sensitive and Castration Resistant Prostate Cancer via Circulating Tumor DNA Sequencing.
Autorzy :
Fan L; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Fei X; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhu Y; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Pan J; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Sha J; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Chi C; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Gong Y; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Du X; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhou L; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Dong B; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Xue W; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Feb; Vol. 205 (2), pp. 461-469. Date of Electronic Publication: 2020 Sep 08.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Sequence Analysis, DNA*
Circulating Tumor DNA/*blood
Circulating Tumor DNA/*genetics
Prostatic Neoplasms/*blood
Prostatic Neoplasms/*genetics
Aged ; Androgen Antagonists/therapeutic use ; Genomics ; Humans ; Male ; Middle Aged ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms, Castration-Resistant/blood ; Prostatic Neoplasms, Castration-Resistant/genetics ; Retrospective Studies
Czasopismo naukowe
Tytuł :
PROACTA: a survey on the actual attitude of the Italian radiation oncologists in the management and prescription of hormonal therapy in prostate cancer patients.
Autorzy :
Fersino S; Radiation Oncology Department, Azienda Provinciale per i Servizi Sanitari, Ospedale S.Chiara, Largo Medaglie d'oro, 9, 38122, Trento, Italy. .
Borghesi S; Radiotherapy Unit- Ospedale S. Donato e Santa Maria alla Gruccia, Azienda USL Toscana Sud, Arezzo, Italy.
Jereczek-Fossa BA; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Arcangeli S; UOC Radioterapia ASST Monza, Università di Milano, Bicocca, Italy.
Mortellaro G; Department of Radiation Oncology, ARNAS Ospedale Civico, Palermo, Italy.
Magrini SM; Department of Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy.
Alongi F; Advanced Radiation Oncology Department, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar-Verona, Italy.; University of Brescia, Brescia, Italy.
Pokaż więcej
Corporate Authors :
Uro-Oncology study group of Italian association of Radiotherapy and Clinical Oncology (AIRO)
Źródło :
La Radiologia medica [Radiol Med] 2021 Mar; Vol. 126 (3), pp. 460-465. Date of Electronic Publication: 2020 Aug 27.
Typ publikacji :
Journal Article
MeSH Terms :
Attitude of Health Personnel*
Radiation Oncologists*
Androgen Antagonists/*therapeutic use
Antineoplastic Agents, Hormonal/*therapeutic use
Health Care Surveys/*statistics & numerical data
Prostatic Neoplasms/*drug therapy
Androstenes/therapeutic use ; Combined Modality Therapy/methods ; Gonadotropin-Releasing Hormone/agonists ; Humans ; Italy ; Male ; Phenylthiohydantoin/analogs & derivatives ; Phenylthiohydantoin/therapeutic use ; Prostatectomy ; Prostatic Neoplasms/radiotherapy ; Prostatic Neoplasms/surgery ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Prostatic Neoplasms, Castration-Resistant/radiotherapy ; Risk Factors ; Salvage Therapy/methods
Czasopismo naukowe
Tytuł :
Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
Autorzy :
Xu MC; Vanderbilt University School of Medicine, Nashville, Tennessee.
Huelster HL; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
Hatcher JB; Vanderbilt University School of Medicine, Nashville, Tennessee.
Avulova S; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
Stocks BT; Vanderbilt University School of Medicine, Nashville, Tennessee.
Glaser ZA; Vanderbilt University School of Medicine, Nashville, Tennessee.
Moses KA; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
Silver HJ; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Mar; Vol. 205 (3), pp. 800-805. Date of Electronic Publication: 2020 Oct 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Obesity/*complications
Prostatic Neoplasms/*pathology
Sarcopenia/*complications
Adipose Tissue/diagnostic imaging ; Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Muscle, Skeletal/diagnostic imaging ; Neoplasm Metastasis ; Neoplasm Staging ; Obesity/diagnostic imaging ; Prostatic Neoplasms, Castration-Resistant/pathology ; Retrospective Studies ; Sarcopenia/diagnostic imaging ; Survival Rate ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Treating Prostate Cancer by Antibody-Drug Conjugates.
Autorzy :
Rosellini M; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Santoni M; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
Mollica V; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Rizzo A; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Cimadamore A; Section of Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60126 Ancona, Italy.
Scarpelli M; Section of Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60126 Ancona, Italy.
Storti N; Direzione Sanitaria Azienda Sanitaria Unica Regionale, 60122 Ancona, Italy.
Battelli N; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
Montironi R; Section of Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60126 Ancona, Italy.
Massari F; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Feb 04; Vol. 22 (4). Date of Electronic Publication: 2021 Feb 04.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antineoplastic Agents, Immunological/*therapeutic use
Immunoconjugates/*therapeutic use
Prostatic Neoplasms/*drug therapy
Animals ; Antineoplastic Agents, Immunological/pharmacology ; Biomarkers, Tumor ; Clinical Trials as Topic ; Disease Management ; Disease Susceptibility ; Humans ; Immunoconjugates/pharmacology ; Male ; Molecular Targeted Therapy ; Prognosis ; Prostatic Neoplasms/etiology ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Prostatic Neoplasms, Castration-Resistant/etiology ; Prostatic Neoplasms, Castration-Resistant/mortality ; Prostatic Neoplasms, Castration-Resistant/pathology ; Standard of Care ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Contemporary management of advanced prostate cancer: an evolving landscape.
Autorzy :
Khanna A; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
O'Connor LP; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Murthy PB; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Bryk DJ; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Fascelli M; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Ericson K; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Yerram NK; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Haywood SC; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Abouassaly R; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Pokaż więcej
Źródło :
Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2021 Feb; Vol. 19 (2), pp. 108-118.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Therapies, Investigational*
Adenocarcinoma/*therapy
Prostatic Neoplasms/*therapy
Adenocarcinoma/diagnostic imaging ; Adenocarcinoma/secondary ; Androstenes/therapeutic use ; Benzamides/therapeutic use ; Clinical Trials as Topic ; Combined Modality Therapy ; Diagnostic Imaging/methods ; Disease Management ; Docetaxel/therapeutic use ; Humans ; Male ; Multicenter Studies as Topic ; Nitriles/therapeutic use ; Phenylthiohydantoin/therapeutic use ; Precision Medicine ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms, Castration-Resistant/diagnostic imaging ; Prostatic Neoplasms, Castration-Resistant/therapy ; Radiotherapy, Adjuvant ; Radium/therapeutic use ; Taxoids/therapeutic use
Czasopismo naukowe
Tytuł :
Exosomes Promote the Transition of Androgen-Dependent Prostate Cancer Cells into Androgen-Independent Manner Through Up-Regulating the Heme Oxygenase-1.
Autorzy :
Zhang Y; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Chen B; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Xu N; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Xu P; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Lin W; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Liu C; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Huang P; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Pokaż więcej
Źródło :
International journal of nanomedicine [Int J Nanomedicine] 2021 Jan 12; Vol. 16, pp. 315-327. Date of Electronic Publication: 2021 Jan 12 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Androgens/*pharmacology
Exosomes/*metabolism
Heme Oxygenase-1/*metabolism
Prostatic Neoplasms/*pathology
Up-Regulation/*drug effects
Animals ; Cell Line, Tumor ; Disease Progression ; Exosomes/ultrastructure ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Mice, Inbred NOD ; Mice, SCID ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms, Castration-Resistant/genetics ; Prostatic Neoplasms, Castration-Resistant/pathology ; Receptors, Androgen/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Three-month early change in prostate-specific antigen levels as a predictive marker for overall survival during hormonal therapy for metastatic hormone-sensitive prostate cancer.
Autorzy :
Nakanishi S; Department of Urology, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Japan. .
Goya M; Department of Urology, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Japan.
Tamaki M; Naha City Hospital, Naha, Okinawa, Japan.
Oshiro T; Naha City Hospital, Naha, Okinawa, Japan.
Saito S; Department of Urology, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Japan.
Pokaż więcej
Źródło :
BMC research notes [BMC Res Notes] 2021 Jun 03; Vol. 14 (1), pp. 227. Date of Electronic Publication: 2021 Jun 03.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms, Castration-Resistant*/drug therapy
Androgen Antagonists/therapeutic use ; Hormones ; Humans ; Male ; Neoplasm Grading ; Prostate-Specific Antigen ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Editorial Comment to Regional and facility disparities in androgen deprivation therapy for prostate cancer from a multi-institutional Japan-wide database.
Autorzy :
Hatakeyama S; Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Ohyama C; Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Pokaż więcej
Źródło :
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2021 May; Vol. 28 (5), pp. 591-592. Date of Electronic Publication: 2021 Mar 04.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms, Castration-Resistant*/drug therapy
Androgen Antagonists/adverse effects ; Androgens ; Antineoplastic Agents, Hormonal/therapeutic use ; Humans ; Japan/epidemiology ; Male
Opinia redakcyjna
Tytuł :
Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance-Does Magnetic Resonance Imaging Have a Role?
Autorzy :
Stonier T; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, New York.; St George's Hospital, London, UK.
Tin AL; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Sjoberg DD; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Jibara G; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, New York.
Vickers AJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Fine S; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, New York.
Eastham J; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, New York.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Apr; Vol. 205 (4), pp. 1063-1068. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Patient Selection*
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*surgery
Aged ; Biopsy ; Humans ; Male ; Middle Aged ; Multiparametric Magnetic Resonance Imaging ; Neoplasm Grading ; Neoplasm Staging ; Prostatectomy ; Prostatic Neoplasms/pathology ; Retrospective Studies ; Risk Factors ; Watchful Waiting
Czasopismo naukowe
Tytuł :
Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pretreatment Prostate Magnetic Resonance Imaging Findings.
Autorzy :
Wibmer AG; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Chaim J; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Lakhman Y; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Lefkowitz RA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Nincevic J; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Nikolovski I; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Sala E; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Gonen M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Carlsson SV; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Urology, Sahlgrenska Academy at University of Gothenburg, Institute of Clinical Sciences, Gothenburg, Sweden.
Fine SW; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Zelefsky MJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Scardino P; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Hricak H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Vargas HA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Apr; Vol. 205 (4), pp. 1055-1062. Date of Electronic Publication: 2020 Nov 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Magnetic Resonance Imaging/*methods
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*therapy
Adult ; Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Neoplasm Invasiveness ; Prognosis ; Prostatectomy ; Prostatic Neoplasms/mortality ; Radiotherapy ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
[TITAN study: evaluation of apalutamide in patients with metastatic hormone-sensitive prostate cancer - Treatment of metastatic hormone-sensitive prostate cancer (mHSPC)].
Autorzy :
Merseburger AS; Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Urology, Lübeck.
Suttmann H; Urologikum Hamburg, Standort Eppendorf, Hamburg.
Pokaż więcej
Transliterated Title :
TITAN-Studie – Evaluation von Apalutamid bei Patienten mit metastasiertem hormonsensitivem Prostatakarzinom.
Źródło :
Aktuelle Urologie [Aktuelle Urol] 2021 Apr; Vol. 52 (2), pp. 155-160. Date of Electronic Publication: 2020 Oct 28.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms, Castration-Resistant*
Androgen Antagonists/adverse effects ; Hormones ; Humans ; Male ; Quality of Life ; Thiohydantoins
Czasopismo naukowe
Tytuł :
Identification of crucial genes and pathways associated with prostate cancer in multiple databases.
Autorzy :
Guo H; School of Clinical Medicine, Bengbu Medical College, Bengbu, China.
Zhang Z; School of Clinical Medicine, Bengbu Medical College, Bengbu, China.
Wang Y; School of Clinical Medicine, Bengbu Medical College, Bengbu, China.
Xue S; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Pokaż więcej
Źródło :
The Journal of international medical research [J Int Med Res] 2021 Jun; Vol. 49 (6), pp. 3000605211016624.
Typ publikacji :
Journal Article
MeSH Terms :
Gene Regulatory Networks*
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/genetics
Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Gene Ontology ; Humans ; Male ; Neoplasm Proteins/genetics ; Neoplasm Recurrence, Local ; Receptors for Activated C Kinase
Czasopismo naukowe
Tytuł :
Prostate Cancer Diagnosis and Management During One Year of the COVID-19 Pandemic.
Autorzy :
Pepe P; Urology Unit, Cannizzaro Hospital, Catania, Italy; .
Pepe L; Urology Unit, Cannizzaro Hospital, Catania, Italy.
Pennisi M; Urology Unit, Cannizzaro Hospital, Catania, Italy.
Fraggetta F; Pathology Unit, Cannizzaro Hospital, Catania, Italy.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Jun; Vol. 41 (6), pp. 3127-3130.
Typ publikacji :
Journal Article
MeSH Terms :
Pandemics*
COVID-19/*epidemiology
Prostatic Neoplasms/*diagnosis
Prostatic Neoplasms/*therapy
COVID-19/virology ; Humans ; Male ; Prostatic Neoplasms/pathology ; SARS-CoV-2/isolation & purification
Czasopismo naukowe
Tytuł :
[Betaine induces apoptosis of C4-2B prostate cancer cells via inhibiting PI3K/AKT/NF-κB signaling pathway].
Autorzy :
Zhang H; Departmen of Urology, General Hospital of Ningxia Medical University, Yinchuan 750004; Second People's Hospital of Luohe City, Luohe 462000, China.
Nie L; Faculty of Physiology, School of Basic Medicine, Ningxia Medical University, Yinchuan 750004, China.
Qin K; Faculty of Physiology, School of Basic Medicine, Ningxia Medical University, Yinchuan 750004, China.
Wang Z; Departmen of Urology, General Hospital of Ningxia Medical University, Yinchuan 750004, China.
Yang B; Faculty of Physiology, School of Basic Medicine, Ningxia Medical University, Yinchuan 750004, China.
Luo Y; Second People's Hospital of Luohe City, Luohe 462000, China.
Zhao R; Departmen of Urology, General Hospital of Ningxia Medical University, Yinchuan 750004, China. *Corresponding author, E-mail: .
Pokaż więcej
Źródło :
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology [Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi] 2021 Jun; Vol. 37 (6), pp. 513-519.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/genetics
Proto-Oncogene Proteins c-akt*/genetics
Proto-Oncogene Proteins c-akt*/metabolism
Apoptosis ; Betaine ; Humans ; Male ; NF-kappa B/genetics ; NF-kappa B/metabolism ; Phosphatidylinositol 3-Kinase ; Phosphatidylinositol 3-Kinases/genetics ; Signal Transduction
Czasopismo naukowe
Tytuł :
Interfractional robustness of scanning carbon ion radiotherapy for prostate cancer: An analysis based on dose distribution from daily in-room CT images.
Autorzy :
Tsuchida K; Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Minohara S; Section of Medical Physics and Engineering, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Kusano Y; Section of Medical Physics and Engineering, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Kano K; Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Anno W; Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Takakusagi Y; Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Mizoguchi N; Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Serizawa I; Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Yoshida D; Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Imura K; Section of Medical Physics and Engineering, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Takayama Y; Section of Medical Physics and Engineering, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Kamada T; Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Katoh H; Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Ohno T; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Pokaż więcej
Źródło :
Journal of applied clinical medical physics [J Appl Clin Med Phys] 2021 Jun; Vol. 22 (6), pp. 130-138. Date of Electronic Publication: 2021 May 27.
Typ publikacji :
Journal Article
MeSH Terms :
Heavy Ion Radiotherapy*
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/radiotherapy
Humans ; Male ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted ; Rectum/diagnostic imaging ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Differences in treatment choices for localised prostate cancer diagnosed in private and public health services.
Autorzy :
Woo HH; Sydney Adventist Hospital, University of Sydney, Sydney, NSW.
Murphy DG; Peter MacCallum Cancer Centre, Melbourne, VIC.
Pokaż więcej
Źródło :
The Medical journal of Australia [Med J Aust] 2021 Jun; Vol. 214 (10), pp. 486-486.e1. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/therapy
Humans ; Male ; Patient Selection ; Prostatectomy ; United States ; United States Public Health Service
Opinia redakcyjna
Tytuł :
Differences in treatment choices for localised prostate cancer diagnosed in private and public health services.
Autorzy :
Mark S; Christchurch Hospital, Christchurch, New Zealand.
Rashid P; University of New South Wales, Sydney, NSW.
Heathcote P; Australian Prostate Cancer Research Centre Queensland, Queensland University of Technology, Brisbane, QLD.
Zargar Shoshtari K; University of Auckland, Auckland, New Zealand.
Pokaż więcej
Źródło :
The Medical journal of Australia [Med J Aust] 2021 Jun; Vol. 214 (10), pp. 485-485.e1. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/therapy
Humans ; Male ; Patient Selection ; Prostatectomy ; United States ; United States Public Health Service
Opinia redakcyjna
Tytuł :
Differences in treatment choices for localised prostate cancer diagnosed in private and public health services.
Autorzy :
Te Marvelde L; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC.
Milne RL; Cancer Council Victoria, Melbourne, VIC.; Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, VIC.
Haines IE; Cabrini Health, Melbourne, VIC.
Pokaż więcej
Źródło :
The Medical journal of Australia [Med J Aust] 2021 Jun; Vol. 214 (10), pp. 486-486.e1. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/therapy
Humans ; Male ; Patient Selection ; Prostatectomy ; United States ; United States Public Health Service
Opinia redakcyjna
Tytuł :
Cystic and cavitating lung lesions as a presenting finding of metastatic prostate cancer.
Autorzy :
Cilento MA; Lyell McEwin Hospital, Adelaide, SA.; University of Adelaide, Adelaide, SA.
Hocking CM; Lyell McEwin Hospital, Adelaide, SA.; University of Adelaide, Adelaide, SA.
Pokaż więcej
Źródło :
The Medical journal of Australia [Med J Aust] 2021 Jun; Vol. 214 (10), pp. 459-459.e1. Date of Electronic Publication: 2021 Apr 22.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Adenocarcinoma/*secondary
Lung Neoplasms/*secondary
Prostatic Neoplasms/*pathology
Adenocarcinoma/diagnostic imaging ; Humans ; Lung Neoplasms/diagnostic imaging ; Male ; Middle Aged ; Prostatic Neoplasms/diagnostic imaging ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Nuclear overexpression levels of MAGE-A3 predict poor prognosis in patients with prostate cancer.
Autorzy :
Khalvandi A; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Abolhasani M; Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran.; Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Madjd Z; Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Shekarabi M; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Kourosh-Arami M; Department of Neuroscience, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mohsenzadegan M; Department of Medical Laboratory Science, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło :
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica [APMIS] 2021 Jun; Vol. 129 (6), pp. 291-303. Date of Electronic Publication: 2021 Apr 13.
Typ publikacji :
Journal Article
MeSH Terms :
Antigens, Neoplasm/*biosynthesis
Biomarkers, Tumor/*metabolism
Neoplasm Proteins/*biosynthesis
Prostatic Neoplasms/*pathology
Aged ; Aged, 80 and over ; Antigens, Neoplasm/analysis ; Biomarkers, Tumor/analysis ; Cell Nucleus/metabolism ; Humans ; Male ; Middle Aged ; Neoplasm Proteins/analysis ; Prognosis ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/mortality ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies